Skip to main content
Premium Trial:

Request an Annual Quote

Locus Pharmaceuticals Taps into IBM s Computing on Demand

NEW YORK, Dec. 2 (GenomeWeb News) - Locus Pharmaceuticals will use supercomputing power from IBM's Deep Computing Capacity on Demand center to support its drug discovery and development activities, IBM said today.

Locus will augment its existing 2.3 teraflop supercomputing infrastructure by tapping into an IBM eServer Linux cluster system located at IBM's on-demand center in Poughkeepsie, New York.

Jeff Wiseman, vice president of technology and informatics at Locus Pharmaceuticals, said that IBM's computer scientists worked with the company to optimize its proprietary drug-design algorithms for the on-demand computing environment.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more